It has been reported that high levels of HK2 correlated with poor clinical outcome in CRC, and this gene may regulate glycolytic metabolism, and then promote cancer cell proliferation and invasion.26 This suggests that lncSLCC1 may bind with AHR and actively regulate HK2 gene expression, and ultimately regulate glycolysis and cell proliferation. The gene discussed is AHR; the disease is cancer.